Downregulating GPX3 expression slowed the proliferation rate of ovarian cancer (Ovcar-4) and colorectal cancer (Lovo, SW480) cells but did not significantly affect the proliferation of breast cancer or gastric cancer cells. This evidence concerns the gene GPX3 and breast cancer.